SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Sierra Oncology Q1 Adj. EPS $(1.310) Up From $(6.090) YoY

Sierra Oncology (NASDAQ:SRRA) reported quarterly losses of $(1.310) per share. This is a 78.49 percent increase over losses of $(6.090) per share from the same period last year.

Benzinga · 05/07/2020 11:18

Sierra Oncology (NASDAQ:SRRA) reported quarterly losses of $(1.310) per share. This is a 78.49 percent increase over losses of $(6.090) per share from the same period last year.